TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00873964 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00006093 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT02589444 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01426100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01700413 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04621864 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT01733628 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03885180 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03388359 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study NCT01226368 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02894853 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02894853 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01295528 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04097158 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04767607 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00567190 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00567190 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00050180 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03703882 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04584528 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04451980 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03221426 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01661153 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02704325 — Predictive Biomarker (PRD): B4GALNT2 mRNA
Genes: B4GALNT2; GALGT2
Study NCT02704325 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02704325 — Predictive Biomarker (PRD): B4GALNT1 mRNA
Genes: B4GALNT1; GALGT; SIAT2
Study NCT03785925 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT00954720 — Predictive Biomarker (PRD): Liver iron
Study NCT03300726 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT03003858 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02029859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03249207 — Safety Biomarker (SAF): Interleukin 1
Study NCT02651168 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02633163 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04400877 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03147131 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02345135 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02345135 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04443803 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00309634 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01734915 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02311842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00521261 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00521261 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00101179 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02812134 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02203825 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05288400 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01379898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04029129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01236573 — Safety Biomarker (SAF): Interleukin 12
Study NCT00109278 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02001285 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01783613 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01685138 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04716764 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT03195647 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04777487 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03094416 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT06171451 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT02361515 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02448030 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00247169 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02585219 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02953340 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT03234387 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03948035 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study NCT03948035 — Predictive Biomarker (PRD): Chromosome 17p
Study NCT02601989 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01258634 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04115306 — Predictive Biomarker (PRD): RPS6KA3 mRNA
Genes: RPS6KA3; ISPK1; MAPKAPK1B; RSK2
Study NCT03558711 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03108807 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05862220 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00108511 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study NCT01955473 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03366324 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03260491 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT03260491 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03260491 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03260491 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03674411 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT04036682 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04036682 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00002788 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00532454 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03213964 — Predictive Biomarker (PRD): FATE1 mRNA
Genes: FATE1; FATE
Study NCT03213964 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00827606 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02637245 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02567253 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02087826 — Predictive Biomarker (PRD): SLC16A11 mRNA
Genes: SLC16A11; MCT11
Study NCT04707742 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT03540784 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01212081 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00906087 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00440947 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT01004406 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00541658 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00777101 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04556773 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01870427 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01680822 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT01748279 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01382992 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02238873 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT00251940 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01035554 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02941263 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01505790 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT03184376 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03184376 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT03184376 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05520697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05520697 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05520697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05919420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01251874 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01251874 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00845650 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04173455 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT00646282 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00627380 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01290380 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01290380 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01290380 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01290380 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04462094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04462094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00203892 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00203892 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT03032055 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01763710 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01763710 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT02532894 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00422344 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT03084926 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02676518 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03439215 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT00342823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02587650 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05054114 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04203524 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00085956 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01443520 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03849417 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03151863 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01012791 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04193007 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study NCT01365260 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00016406 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00157573 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00802542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02318667 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT02318667 — Safety Biomarker (SAF): Interleukin 1
Study NCT00236015 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02347098 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05698082 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT04315675 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06593743 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03799250 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04456179 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01838109 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04503525 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01789515 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT03538314 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01372384 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03410173 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT04360551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02634268 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00780247 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01353222 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04625634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01392534 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01545479 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03603951 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT04503499 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03488160 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04417036 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT02686242 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04000698 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00155766 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04004637 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT00542880 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04113408 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT00274079 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03499691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03499691 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT03499691 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02107638 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT04046003 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04046003 — Safety Biomarker (SAF): BDNF
Study NCT04285892 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT00271596 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02030808 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00696384 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01066039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02460861 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study NCT01547897 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT01547897 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT04472585 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01950559 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00607633 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02195518 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00191256 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02232308 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT04295005 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01639066 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00491348 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00061542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02887079 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02887079 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03333343 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04924738 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01029275 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT01142401 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02435186 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04205318 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT01074398 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT03699579 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03699579 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02657746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03175367 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03383341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04443712 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04386304 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT00894816 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01334177 — Predictive Biomarker (PRD): TLR8 mRNA
Genes: TLR8; UNQ249/PRO286
Study NCT02642445 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04023669 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT04023669 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT02395601 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT03088449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00739375 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT00739375 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03817411 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01292486 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03706859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00685412 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02689427 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02477059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00402207 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01004224 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT02351193 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04958148 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02434172 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03536208 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT01826019 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01350947 — Surrogate Endpoint (SUR): Hematologic response
Study NCT02994459 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT04658524 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT03655808 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03234595 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03982121 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03982121 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04351334 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00119405 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT01547923 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study NCT03982004 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03460795 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03446066 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT00005161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03157817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03923166 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04738422 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04597736 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04425187 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02095210 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00309309 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01887366 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341